ASX - By Stock
|
SPL |
Re:
manipulation at its best
|
|
bid
|
18 |
3.5K |
8 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
18
|
3.5K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
manipulation at its best
|
|
bid
|
18 |
3.5K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
18
|
3.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
manipulation at its best
|
|
bid
|
18 |
3.5K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
18
|
3.5K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
44
|
6.8K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
44
|
6.8K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
44
|
6.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma Delegation @ ASCO 2024
|
|
bid
|
13 |
3.2K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
13
|
3.2K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP outperforms leading treatments in ovarian cancer model
|
|
bid
|
14 |
3.9K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
14
|
3.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP outperforms leading treatments in ovarian cancer model
|
|
bid
|
14 |
3.9K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
14
|
3.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
48hrs post Major +ve Announcement
|
|
bid
|
9 |
1.8K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
9
|
1.8K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
48hrs post Major +ve Announcement
|
|
bid
|
9 |
1.8K |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
9
|
1.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
bid
|
42 |
10K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
bid
|
42 |
10K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
bid
|
42 |
10K |
9 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
10K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
44
|
6.8K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
44
|
6.8K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
44
|
6.8K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
6 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
44
|
6.8K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not over by a long shot
|
|
bid
|
44 |
6.8K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
44
|
6.8K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
DEP Phase 3 trials no certainty
|
|
bid
|
11 |
1.6K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
1.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
DEP Phase 3 trials no certainty
|
|
bid
|
11 |
1.6K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
1.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
C'mon Friday 24th May
|
|
bid
|
11 |
2.7K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
2.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
When multiple potential partners say yeah nah, not interested.
|
|
bid
|
32 |
6.6K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
32
|
6.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
DEP Phase 3 trials no certainty
|
|
bid
|
11 |
1.6K |
0 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
11
|
1.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
SPL Announcements moving forward
|
|
bid
|
5 |
853 |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
5
|
853
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Radiopharmaceuticals
|
|
bid
|
18 |
5.3K |
6 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
18
|
5.3K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Radiopharmaceuticals
|
|
bid
|
18 |
5.3K |
2 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
18
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
33
|
6.4K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
bid
|
33 |
6.4K |
5 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
33
|
6.4K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
bid
|
29 |
6.2K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
6.2K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
bid
|
29 |
6.2K |
8 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
6.2K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to cry?
|
|
bid
|
4 |
1.1K |
3 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
4
|
1.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
bid
|
9 |
2.9K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
bid
|
9 |
2.3K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
bid
|
9 |
2.9K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.9K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
bid
|
9 |
2.9K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.9K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
bid
|
13 |
2.4K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.4K
|
0
|
|
ASX - By Stock
|
SPL |
Medicxi and Starpharma.
|
|
bid
|
10 |
3.1K |
6 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
10
|
3.1K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
bid
|
13 |
2.4K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.4K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
bid
|
13 |
2.4K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Looks like the fat lady has not yet sung on AZD4320
|
|
bid
|
31 |
7.5K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
31
|
7.5K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Looks like the fat lady has not yet sung on AZD4320
|
|
bid
|
31 |
7.5K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
31
|
7.5K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
bid
|
148 |
29K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
148
|
29K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
bid
|
148 |
29K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
148
|
29K
|
4
|
|